Prasad's stint included several controversial vaccine decisions; the FDA is now searching for a new head for its vaccine division.

Keir Starmer faces a key test as a special election threatens to deepen the UK Labour Party’s crisis and his own leadership troubles. On Thursday, voters in the longtime Labour stronghold of ...

Prasad’s planned departure, expected at the end of April, culminates a tumultuous term in which he reworked vaccine guidelines and was criticized for his office’s stance on several rare disease drugs.

This year, at least when it comes to “guidance,” there is an agenda for the “F in the FDA,” which is officially known inside the agency as the Human Foods Program. U.S. Food and Drug Administration ...

The Food and Drug Administration’s head of vaccines and biotechnology drugs, Dr. Vinay Prasad, is leaving the agency as of ...

Add Yahoo as a preferred source to see more of our stories on Google. FILE PHOTO: FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S ...

WASHINGTON—In an hour-long meeting in January, Food and Drug Administration career staff laid out their objections to a plan to block a new flu shot from vaccine maker Moderna. They argued that ...

Federal health officials said Tuesday they will reassess the safety of a chemical called BHA used in foods including potato chips, cereals, frozen meals and meat products. The U.S. Food and Drug ...

After years of maintaining a policy that any added color in food is “artificial color,” the U.S. Food and Drug Administration (FDA) issued a letter to industry announcing that it will exercise ...

Feb. 10 (UPI) --The Food and Drug Administration announced Tuesday it's undertaking a review of the chemical preservative butylated hydroxyanisole to determine if the potentially carcinogenic ...

The U.S. Food and Drug Administration (FDA) has issued an important safety advisory regarding eight lots of RAAW Energy raw dog food. According to a press release from the New Jersey Department of ...

The Food and Drug Administration rejected Moderna’s application for its mRNA-based flu vaccine, the drugmaker said Tuesday. The move is the latest sign that the FDA, under Health Secretary Robert F.